Thromboembolic risks in patients with COVID-19: major concern to consider in our management.
COVID-19
Thromboembolism risks
management
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
04
2020
accepted:
21
04
2020
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients.
Identifiants
pubmed: 32528621
doi: 10.11604/pamj.2020.35.2.22945
pii: PAMJ-SUPP-35-2-10
pmc: PMC7266474
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
10Informations de copyright
© Mazou Ngou Temgoua et al.
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Dis Mon. 2019 Aug;65(8):249-298
pubmed: 30638566
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Lancet Haematol. 2020 May;7(5):e362-e363
pubmed: 32278361
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Thromb Haemost. 2010 Nov;8(11):2450-7
pubmed: 20738765